Nutrastar International (NUIN) Return on Equity ROE from the third quarter 2015 to third quarter 2014 and annually, average high and low, overall ranking from Sep 30 2015 to Sep 30 2014 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nutrastar International Inc.  (NUIN)

Nutrastar International's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Nutrastar International in the third quarter 2015?
Nutrastar International Inc. achieved a return on average equity (ROE) of 16.02 % in its third quarter 2015, which is below Nutrastar International's average return on equity, which stands at 19.13%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Biotechnology & Pharmaceuticals industry 7 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2015 from 0 to 766.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2015)
III. Quarter		 (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter
Y / Y Equity Change 13.85 % 19.34 % 19.64 % 19.51 % -
Y / Y Net Income Change -1.13 % 4.15 % 9.2 % -5.44 % 4.83 %
Net Income (TTM) in Millions 23 23 23 23 23
Return On Equity (TTM) 16.02 % 16.59 % 17.12 % 17.67 % 18.79 %
NUIN's Total Ranking # 766 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 150 150 142 139 132
Seq. Equity Change 0.04 % 5.46 % 2.19 % 5.59 % 4.87 %
Seq. Net Income Change -15.35 % 100.44 % -46.75 % 9.43 % -10.83 %

Back to NUIN Management Effectiveness >> NUIN's 5 Years Annual ROE >> Compare NUIN ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 8
Sector # 87
Overall # 766

Return On Equity Statistics
High Average Low
21.17 %
19.13 %
16.02 %
(Sep 30 2013)   (Sep 30 2015)





NUIN Annual Return On Equity (Dec 31 2014)
2014		 (Dec 31 2013)
2013		 (Dec 31 2012)
2012		 (Dec 31 2011)
2011
Total Equity in Millions 139 116 90 72 0
Y / Y Equity Change 19.51 % 28.67 % 25.38 % - -
Net Income in Millions 23 22 17 17 0
Y / Y Net Income Change 2.48 % 28.58 % 1.53 % - -
Return On Equity 16.36 % 19.08 % 19.1 % 23.58 % -

Back to NUIN Management Effectiveness >> NUIN's 5 Years Annual ROE >> Compare NUIN ROE to its Competitors




Annual Roe Comment
In 2014 ROE fell to 16.36 %, despite net income growth.


More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
NUIN's' Return on Equity at Yahoo Finance
NUIN's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for NUIN's Competitors
Subscribers only: Roe for Nutrastar International's Suppliers
Subscribers only: Return On Equity for NUIN's Customers




Companies with similar Return On Equity at Sep 30 2015, within Healthcare Sector ROE
3m Company  37.97 %
Enanta Pharmaceuticals Inc  37.74 %
National Healthcare Corp  37.41 %
Pacific Health Care Organization Inc  36.99 %
China Biologic Products Holdings Inc   36.14 %
Zoetis Inc   34.92 %
Encompass Health Corporation  34.74 %
Lannett Company Inc  33.45 %
Teligent Inc   32.10 %
Biogen Inc   32.05 %
Akorn Inc  30.10 %
Illumina Inc   29.80 %
Vanda Pharmaceuticals Inc   29.33 %
Sientra Inc   27.93 %
Lakeland Industries Inc   26.79 %
Celgene Corp  26.49 %
Masimo Corp  26.41 %
Iridex Corp  26.31 %
Cambrex Corp  25.53 %
Varian Medical Systems Inc   24.97 %
St Jude Medical Inc  24.96 %
Biospecifics Technologies Corp  24.78 %
Adaptive Biotechnologies Corporation  24.65 %
Journey Medical Corp  24.59 %
Waters Corporation  24.51 %
Amag Pharmaceuticals inc   24.40 %
Ani Pharmaceuticals Inc  24.29 %
Misonix Inc   23.27 %
Chemed Corporation  23.26 %
Jazz Pharmaceuticals Plc  23.10 %

Date modified: 2026-09-26T07:15:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.